Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three separate medications: **Methylprednisolone** is a corticosteroid used to treat inflammation or immune reactions across various organ systems, endocrine conditions, and neoplastic disorders. It works by calming certain chemicals in the body to reduce inflammation. **Prednisolone** is also a corticosteroid with similar anti-inflammatory and immunosuppressive properties. **Tranexamic acid** is an antifibrinolytic agent that reduces bleeding by stopping the breakdown of blood clots. It's commonly used to reduce heavy menstrual bleeding and in various surgical settings to minimize blood loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylprednisolone + prednisolone + tranexamic acid.